Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best? [PDF]
Chakravarty R +3 more
europepmc +1 more source
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]
Klomp MJ +4 more
europepmc +1 more source
Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer. [PDF]
Nguyen NT +5 more
europepmc +1 more source
Gravity versus pump-driven infusion in targeted radionuclide therapy: a model-based dosimetric evaluation of extravasation. [PDF]
Lienhardt O +7 more
europepmc +1 more source
Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles. [PDF]
Kleinendorst SC +12 more
europepmc +1 more source
An Appendix of Radionuclides Used in Targeted Alpha Therapy [PDF]
Maryline G, Ferrier, Valery, Radchenko
openaire +2 more sources
A Targeted Radionuclide Therapy Facility at a University Teaching Hospital in Singapore. [PDF]
Chia KL +6 more
europepmc +1 more source
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy. [PDF]
Garcia-Prada CD +14 more
europepmc +1 more source
Low Radioactivity Levels in Blood Samples After Targeted Radionuclide Therapy: Minimal Radiation Exposure of Healthcare Staff. [PDF]
Wehmann M +5 more
europepmc +1 more source
Chelator Optimization and Therapeutic Potential of <sup>188</sup>Re-FAPI for FAP-Targeted Radionuclide Therapy. [PDF]
Liang SH.
europepmc +1 more source

